Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
1.920
+0.030 (1.59%)
At close: Oct 27, 2026, 4:00 PM EDT
1.870
-0.050 (-2.60%)
After-hours: Oct 27, 2026, 4:10 PM EDT
Niki BioSolutions Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
5.64M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 431.38K | -864.51K | -66.71% |
| Dec 31, 2022 | 1.30M | -245.89K | -15.95% |
| Dec 31, 2021 | 1.54M | 630.27K | 69.15% |
| Dec 31, 2020 | 911.51K | 376.34K | 70.32% |
| Dec 31, 2019 | 535.17K | 151.72K | 39.57% |
| Dec 31, 2018 | 383.45K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Traws Pharma | 2.73M |
| Evogene | 1.66M |
| Longeveron | 1.19M |
| Can-Fite BioPharma | 405.00K |
| Senti Biosciences Holdings | 55.00K |
| Aprea Therapeutics | 5.19K |
| Alaunos Therapeutics | 3.00K |
| Pulmatrix | 3.00K |
NIKI News
- 1 day ago - Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine - GlobeNewsWire
- 4 days ago - Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research - GlobeNewsWire
- 11 days ago - Niki BioSolutions' Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation's “Rett Research Tool Belt” Series - GlobeNewsWire
- 13 days ago - Niki BioSolutions Partners with Global Alzheimer's Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002 - GlobeNewsWire
- 4 weeks ago - Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference - GlobeNewsWire
- 6 weeks ago - Niki BioSolutions Accelerates Its Alzheimer's Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics - GlobeNewsWire
- 7 weeks ago - Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Niki BioSolutions files $75M mixed securities shelf - TheFly